Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

tablet

tablet is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 1,071
News articles 0
Drug details — tablet
Class
—
Route
—
Patents
20
Programs
1071
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

tablet is an FDA-listed pharmaceutical active ingredient.

Key facts

INN tablet

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 042011 Phase 3 · George Institute for · Langerhans Cell Histiocytosis
  2. 1245-0256 Phase 3 · Boehringer Ingelheim · Chronic kidney disease in paediatric patients
  3. 1378-0041 Phase 3 · Boehringer Ingelheim · Type 2 diabetes, hypertension, cardiovascular disease
  4. 156-201-00307 Phase 3 · Otsuka Beijing Research · Autosomal Recessive Polycystic Kidney Disease
  5. 1821-FSH-301 Phase 3 · Fulcrum Therapeutics · Facioscapulohumeral Muscular Dystrophy (FSHD)
  6. 19920 Phase 3 · Bayer · Proteinuria, Chronic kidney disease
  7. 2.16/VI/22 Phase 3 · Cardiol Therapeutics · Patients with functionally single ventricle (FSV - functiona
  8. 2019/ABM/01/00074 Phase 3 · Bial Portela & · Chronic obstructive pulmonary disease (COPD)

Related patents

Browse patents

  1. US 12415794

    Pyridazinone compounds and uses thereof

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12318487

    Solid tablet dosage form of ridinilazole

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12240831

    Pyridazinone compounds and uses thereof

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12240833

    Pyridazinone compounds and uses thereof

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12060327

    Psychotropic agents and uses thereof

    Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12048691

    High dosage tebipenem pivoxil tablet formulation

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12012395

    Pyridazinone compounds and uses thereof

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11713295

    Psychotropic agents and uses thereof

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 2022354866

    IMMEDIATE RELEASE MULTILAYER TABLET

    Expires Wed Nov 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11390606

    Pyridazinone compounds and uses thereof

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11377421

    Psychotropic agents and uses thereof

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11253445

    Oxidative hair color remover in tablet or pellet form

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11236065

    Pyridazinone compounds and uses thereof

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11091464

    Pyridazinone compounds and uses thereof

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11040943

    Psychotropic agents and uses thereof

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10689338

    Psychotropic agents and uses thereof

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. EP 3539539

    TABLETTENFORMULIERUNGEN AUS (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLIN-1,3-DION

    Expires Tue Sep 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10259786

    Psychotropic agents and uses thereof

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10238605

    Dry coated tablet

    Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10167256

    Psychotrophic agents and uses thereof

    Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is tablet?

tablet is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.